{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:20Z","timestamp":1792787900005,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This research was funded by Scientific Research Fund of Health Department of Zhejiang Province, grant number","award":["2024KY640"],"award-info":[{"award-number":["2024KY640"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11472-7","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T06:00:46Z","timestamp":1755583246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk factors for bloodstream infection and predictors of prognosis in rectal carriers of carbapenem-resistant Klebsiella pneumoniae"],"prefix":"10.1186","volume":"25","author":[{"given":"Miaomiao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"11472_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ebiom.2017.04.032","volume":"19","author":"R Zhang","year":"2017","unstructured":"Zhang R, Liu L, Zhou H, Chan EW, Li J, Fang Y, et al. Nationwide surveillance of clinical carbapenem-resistant Enterobacteriaceae (CRE) strains in China. EBioMedicine. 2017;19:98\u2013106. https:\/\/doi.org\/10.1016\/j.ebiom.2017.04.032.","journal-title":"EBioMedicine"},{"issue":"8","key":"11472_CR2","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1128\/AAC.00299-07","volume":"51","author":"A Leavitt","year":"2007","unstructured":"Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother. 2007;51:3026\u20139. https:\/\/doi.org\/10.1128\/AAC.00299-07.","journal-title":"Antimicrob Agents Chemother"},{"issue":"254","key":"11472_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1126\/scitranslmed.3009845","volume":"6","author":"S Conlan","year":"2014","unstructured":"Conlan S, Thomas PJ, Deming C, Park M, Lau AF, Dekker JP, et al. Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae. Sci Transl Med. 2014;6(254):254\u2013126. https:\/\/doi.org\/10.1126\/scitranslmed.3009845.","journal-title":"Sci Transl Med"},{"issue":"5","key":"11472_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1017\/ice.2017.42","volume":"38","author":"ND Friedman","year":"2017","unstructured":"Friedman ND, Carmeli Y, Walton AL, Schwaber MJ. Carbapenem-resistant enterobacteriaceae: a strategic roadmap for infection control. Infect Control Hosp Epidemiol. 2017;38(5):580\u201394. https:\/\/doi.org\/10.1017\/ice.2017.42.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"11472_CR5","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1586\/14787210.2013.836057","volume":"11","author":"P Viale","year":"2013","unstructured":"Viale P, Giannella M, Lewis R, Trecarichi EM, Petrosillo N, Tumbarello M. Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections. Expert Rev Anti-Infective Therapy. 2013;11(10):1053\u201363. https:\/\/doi.org\/10.1586\/14787210.2013.836057.","journal-title":"Expert Rev Anti-Infective Therapy"},{"issue":"9","key":"11472_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","volume":"13","author":"LS Munoz-Price","year":"2013","unstructured":"Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785\u201396. https:\/\/doi.org\/10.1016\/S1473-3099(13)70190-7.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"11472_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13054-025-05266-1","volume":"29","author":"G De Pascale","year":"2025","unstructured":"De Pascale G, Cortegiani A, Rinaldi M, Antonelli M, Cattaneo S, Cecconi M, INCREASE-IT Study Group, et al. Incidence of hospital-acquired infections due to carbapenem-resistant enterobacterales and Pseudomonas aeruginosa in critically ill patients in Italy: a multicentre prospective cohort study. Crit Care. 2025;29(1):32. https:\/\/doi.org\/10.1186\/s13054-025-05266-1.","journal-title":"Crit Care"},{"issue":"2","key":"11472_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40121-022-00732-7","volume":"12","author":"M Li","year":"2023","unstructured":"Li M, Yang S, Yao H, Liu Y, Du M. Retrospective analysis of epidemiology, risk factors, and outcomes of health care-acquired carbapenem-resistant Klebsiella pneumoniae bacteremia in a Chinese tertiary hospital, 2010\u20132019. Infect Dis Ther. 2023;12(2):473\u201385. https:\/\/doi.org\/10.1007\/s40121-022-00732-7.","journal-title":"Infect Dis Ther"},{"issue":"2","key":"11472_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.diagmicrobio.2012.11.009","volume":"75","author":"DD Van Duin","year":"2013","unstructured":"Van Duin DD, Kaye KS, Neuner EA, Bonomo RA. Carbapenem-resistant enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis. 2013;75(2):115\u201320. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2012.11.009.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"11472_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1469-0691.2011.03478.x","volume":"18","author":"D Ben-David","year":"2012","unstructured":"Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal-Mor O, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2012;18(1):54\u201360. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03478.x.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"11472_CR11","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1086\/599392","volume":"30","author":"K Hussein","year":"2009","unstructured":"Hussein K, Sprecher H, Mashiach T, et al. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol. 2009;30(7):666\u201371. https:\/\/doi.org\/10.1086\/599392.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"11472_CR12","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1001\/archinte.165.12.1430","volume":"165","author":"S Bratu","year":"2005","unstructured":"Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York city: a new threat to our antibiotic armamentarium. Arch Intern Med. 2005;165(12):1430\u20135. https:\/\/doi.org\/10.1001\/archinte.165.12.1430.","journal-title":"Arch Intern Med"},{"issue":"148","key":"11472_CR13","doi-asserted-by":"publisher","first-page":"148ra116","DOI":"10.1126\/scitranslmed.3004129","volume":"4","author":"ES Snitkin","year":"2012","unstructured":"Snitkin ES, Zelazny AM, Thomas PJ, Stock F, NISC Comparative Sequencing Program Group, Henderson DK, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med. 2012;4(148):148ra116. https:\/\/doi.org\/10.1126\/scitranslmed.3004129.","journal-title":"Sci Transl Med"},{"issue":"5","key":"11472_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jinf.2022.03.010","volume":"84","author":"T Lou","year":"2022","unstructured":"Lou T, Du X, Zhang P, Shi Q, Han X, Lan P, Yan R, Hu H, Wang Y, Wu X, Jiang Y, Yu Y. Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: a large multicentre case-control and cohort study. J Infect. 2022;84(5):637\u201347. https:\/\/doi.org\/10.1016\/j.jinf.2022.03.010.","journal-title":"J Infect"},{"key":"11472_CR15","doi-asserted-by":"publisher","first-page":"750662","DOI":"10.3389\/fmicb.2021.750662","volume":"12","author":"D Chang","year":"2021","unstructured":"Chang D, Sharma L, Dela Cruz CS, Zhang D, Clinical, Epidemiology. Risk factors, and control strategies of Klebsiella pneumoniae infection. Front Microbiol. 2021;12:750662. https:\/\/doi.org\/10.3389\/fmicb.2021.750662.","journal-title":"Front Microbiol"},{"issue":"Suppl 2","key":"11472_CR16","doi-asserted-by":"publisher","first-page":"S206","DOI":"10.1093\/infdis\/jiz622","volume":"221","author":"X Qin","year":"2020","unstructured":"Qin X, Wu S, Hao M, Zhu J, Ding B, Yang Y, Xu X, Wang M, Yang F, Hu F. The colonization of Carbapenem-Resistant Klebsiella pneumoniae: epidemiology, resistance mechanisms, and risk factors in patients admitted to intensive care units in China. J Infect Dis. 2020;221(Suppl 2):S206\u201314. https:\/\/doi.org\/10.1093\/infdis\/jiz622.","journal-title":"J Infect Dis"},{"key":"11472_CR17","volume-title":"Performance standards for antimicrobial susceptibility testing: M100-S30","author":"Clinical and Laboratory Standards Institute","year":"2020","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: M100-S30. Wayne: Clinical and Laboratory Standards Institute; 2020."},{"key":"11472_CR18","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST disk diffusion breakpoints for interpretation of zone diameters - version 10.0. 2020. https:\/\/eucast.org\/clinical_breakpoints\/."},{"issue":"4","key":"11472_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jinf.2016.07.002","volume":"73","author":"MJ Satlin","year":"2016","unstructured":"Satlin MJ, Cohen N, Ma KC, Gedrimaite Z, Soave R, Askin G, et al. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies. J Infect. 2016;73:336\u201345. https:\/\/doi.org\/10.1016\/j.jinf.2016.07.002.","journal-title":"J Infect"},{"issue":"1","key":"11472_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jiph.2018.08.002","volume":"12","author":"C Li","year":"2019","unstructured":"Li C, Li Y, Zhao Z, Liu Q, Li B. Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital. J Infect Public Health. 2019;12(1):26\u201331. https:\/\/doi.org\/10.1016\/j.jiph.2018.08.002.","journal-title":"J Infect Public Health"},{"issue":"11","key":"11472_CR21","doi-asserted-by":"publisher","first-page":"e11061","DOI":"10.1016\/j.cmi.2015.08.001","volume":"21","author":"DR Giacobbe","year":"2015","unstructured":"Giacobbe DR, Del Bono V, Trecarichi EM, De Rosa FG, Giannella M, Bassetti M, ISGRI-SITA (Italian Study Group on Resistant Infections of the Societ\u00e0 Italiana Terapia Antinfettiva), et al. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control study. Clin Microbiol Infect. 2015;21(11):e11061\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"11472_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3855\/jidc.6697","volume":"10","author":"Y Hu","year":"2016","unstructured":"Hu Y, Ping Y, Li L, Xu H, Yan X, Dai H. A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients. J Infect Developing Ctries. 2016;10(2):208\u201313. https:\/\/doi.org\/10.3855\/jidc.6697.","journal-title":"J Infect Developing Ctries"},{"key":"11472_CR23","volume-title":"Guidelines on core components of infection prevention and control programmes at the National and acute health care facility level","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Guidelines on core components of infection prevention and control programmes at the National and acute health care facility level. Geneva: World Health Organization; 2016."},{"issue":"10","key":"11472_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.15585\/mmwr.mm5810a1","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","unstructured":"Centers for Disease Control and Prevention (CDC). Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. Morb Mortal Wkly Rep. 2009;58(10):256\u201360. https:\/\/doi.org\/10.15585\/mmwr.mm5810a1.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"2","key":"11472_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/bmt.2014.207","volume":"50","author":"C Girmenia","year":"2015","unstructured":"Girmenia C, Rossolini GM, Piciocchi A, et al. Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy. Bone Marrow Transplant. 2015;50(2):282\u20138. https:\/\/doi.org\/10.1038\/bmt.2014.207.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"11472_CR26","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/jac\/dkv479","volume":"71","author":"Y Fraenkel-Wandel","year":"2016","unstructured":"Fraenkel-Wandel Y, Raveh-Brawer D, Wiener-Well Y, et al. Mortality due to BlaKPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother. 2016;71(4):1083\u20137. https:\/\/doi.org\/10.1093\/jac\/dkv479.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"11472_CR27","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/cid\/cis378","volume":"55","author":"M Tumbarello","year":"2012","unstructured":"Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55(7):943\u201350. https:\/\/doi.org\/10.1093\/cid\/cis378.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"11472_CR28","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s00134-004-2210-z","volume":"30","author":"RP Dellinger","year":"2004","unstructured":"Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004;30(4):536\u201355. https:\/\/doi.org\/10.1007\/s00134-004-2210-z.","journal-title":"Intensive Care Med"},{"key":"11472_CR29","unstructured":"Centers for Disease Control and Prevention (CDC). CDC\/NHSN surveillance definitions for specific types of infections. http:\/\/www.cdc.gov\/nhsn\/PDFs\/pscManual\/17pscNosInfDef_current.pdf."},{"issue":"6","key":"11472_CR30","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/jac\/dkr116","volume":"66","author":"EI Kritsotakis","year":"2011","unstructured":"Kritsotakis EI, Tsioutis C, Roumbelaki M, Christidou A, Gikas A. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-\u03b2-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J Antimicrob Chemother. 2011;66(6):1383\u201391. https:\/\/doi.org\/10.1093\/jac\/dkr116.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"11472_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/cid\/cix370","volume":"65","author":"DJA Toth","year":"2017","unstructured":"Toth DJA, Khader K, Slayton RB, Kallen AJ, Gundlapalli AV, O\u2019Hagan JJ, et al. The potential for interventions in a long-term acute care hospital to reduce transmission of carbapenem-resistant Enterobacteriaceae in affiliated healthcare facilities. Clin Infect Dis. 2017;65(5):581\u20137.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"11472_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11908-019-0679-4","volume":"21","author":"O Smibert","year":"2019","unstructured":"Smibert O, Satlin MJ, Nellore A, Peleg AY. Carbapenem-resistant Enterobacteriaceae in solid organ transplantation: management principles. Curr Infect Dis Rep. 2019;21:26. https:\/\/doi.org\/10.1007\/s11908-019-0679-4.","journal-title":"Curr Infect Dis Rep"},{"issue":"Suppl 1","key":"11472_CR33","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","volume":"215","author":"LK Logan","year":"2017","unstructured":"Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017;215(Suppl 1):S28\u201336. https:\/\/doi.org\/10.1093\/infdis\/jiw282.","journal-title":"J Infect Dis"},{"issue":"10","key":"11472_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.33594\/000000012","volume":"5","author":"A Esmael","year":"2021","unstructured":"Esmael A. How does corticosteroid medication affect the immune system? Arch Gen Intern Med. 2021;5(10):8. https:\/\/doi.org\/10.33594\/000000012.","journal-title":"Arch Gen Intern Med"},{"issue":"2","key":"11472_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.mib.2013.01.003","volume":"16","author":"A Khosravi","year":"2013","unstructured":"Khosravi A, Mazmanian SK. Disruption of the gut Microbiome as a risk factor for microbial infections. Curr Opin Microbiol. 2013;16(2):221\u20137. https:\/\/doi.org\/10.1016\/j.mib.2013.01.003.","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"11472_CR36","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/ajg.2013.76","volume":"108","author":"CM Surawicz","year":"2013","unstructured":"Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of clostridium difficile infections. Am J Gastroenterol. 2013;108(4):478\u201398. https:\/\/doi.org\/10.1038\/ajg.2013.76.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"11472_CR37","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nri2654","volume":"9","author":"JL Round","year":"2009","unstructured":"Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(11):607\u201318. https:\/\/doi.org\/10.1038\/nri2654.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"11472_CR38","doi-asserted-by":"publisher","first-page":"e02529","DOI":"10.1128\/AAC.02529-19","volume":"64","author":"RK Shields","year":"2020","unstructured":"Shields RK, Chen L, Cheng S, Chavda KD, Press EG, Snyder A, et al. Ceftazidime-Avibactam mics and resistance mechanisms in KPC-Producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2020;64(3):e02529\u201319. https:\/\/doi.org\/10.1128\/AAC.02529-19.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"11472_CR39","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/jac\/dkaa479","volume":"76","author":"I Karaiskos","year":"2021","unstructured":"Karaiskos I, Daikos GL, Gkoufa A, et al. Ceftazidime\/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a National registry study. J Antimicrob Chemother. 2021;76(3):775\u201383. https:\/\/doi.org\/10.1093\/jac\/dkaa479.","journal-title":"J Antimicrob Chemother"},{"key":"11472_CR40","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.3389\/fmicb.2018.03341","volume":"9","author":"M Miao","year":"2018","unstructured":"Miao M, Wen H, Xu P, et al. Genetic diversity of carbapenem-resistant Enterobacteriaceae (CRE) clinical isolates from a tertiary hospital in Eastern China. Front Microbiol. 2018;9:3341. https:\/\/doi.org\/10.3389\/fmicb.2018.03341.","journal-title":"Front Microbiol"},{"issue":"1","key":"11472_CR41","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12866-023-03058-7","volume":"23","author":"S Tao","year":"2023","unstructured":"Tao S, Chen H, Li N, et al. Elimination of blaKPC\u2013\u20092-mediated carbapenem resistance in Escherichia coli by CRISPR-Cas9 system. BMC Microbiol. 2023;23(1):310. https:\/\/doi.org\/10.1186\/s12866-023-03058-7.","journal-title":"BMC Microbiol"},{"issue":"12","key":"11472_CR42","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1128\/aac.03911-14","volume":"58","author":"P Yang","year":"2014","unstructured":"Yang P, Xie Y, Feng P, Zong Z. blaNDM-5 carried by an IncX3 plasmid in Escherichia coli sequence type 167. Antimicrob Agents Chemother. 2014;58(12):7374\u20137. https:\/\/doi.org\/10.1128\/aac.03911-14.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"11472_CR43","doi-asserted-by":"publisher","first-page":"S196","DOI":"10.1093\/cid\/ciy660","volume":"67","author":"Q Wang","year":"2018","unstructured":"Wang Q, Wang X, Wang J, Ouyang P, Jin C, Wang R, et al. Phenotypic and genotypic characterization of carbapenem-resistant enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012\u20132016). Clin Infect Dis. 2018;67(Suppl 2):S196\u2013205.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"11472_CR44","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/cid\/ciad765","volume":"78","author":"D Wang","year":"2024","unstructured":"Wang D, Zhang Y, Li X, et al. National surveillance of carbapenem-resistant Enterobacteriaceae in china: trends and molecular epidemiology (2018\u20132022). Clin Infect Dis. 2024;78(5):776\u201385. https:\/\/doi.org\/10.1093\/cid\/ciad765.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11472-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11472-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11472-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:49:13Z","timestamp":1757436553000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11472-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11472"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11472-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and relevant guidelines. The protocol was approved by the Ethics Committee of Zhejiang Provincial People\u2019s Hospital (approval number: 2022QT013). Given that all data analyzed in this retrospective study were de-identified and anonymized (with no personally identifiable information accessible), the requirement for informed consent from participants was waived by the Ethics Committee of Zhejiang Provincial People\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1037"}}